Non-opioid Pain Patch Market size was valued at USD 3.61 billion in 2024 and is likely to reach USD 6.16 billion by the end of 2037, registering around 4.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of non-opioid pain patch is assessed at USD 3.73 billion. The reason behind the growth is due to the growing burden of diabetes across the globe. Diabetic neuropathy may present as the initial symptom of diabetes caused by excessive blood sugar levels that harm the nerves resulting in pain and discomfort in the hands, feet, or limbs.
According to the World Health Organization (WHO), around 422 million individuals globally suffer from diabetes, and the disease is directly responsible for roughly 1.5 million fatalities annually.
The growing development of advanced products is believed to fuel the non-opioid pain patch market growth. For instance, A scientific team led by Duke University has created a biocompatible polymer patch surgical patch that dissolves after releasing non-opioid medicines and it is assumed that during the crucial period following surgery, the patch should be able to manage wound discomfort for three or four days.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?